Faculty profile
Andreas Maetzel
Back to facultyResearch
Read how they describe their research on their University of Toronto profile.
Latest papers
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial.
Lancet (London, England) · 2023
Hereditary Angioedema With Normal C1 Inhibitor: US Survey of Prevalence and Provider Practice Patterns.
The journal of allergy and clinical immunology. In practice · 2023
Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2022
9 publications.
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial.
Aygören-Pürsün E, Zanichelli A, Cohn DM, Cancian M, Hakl R, Kinaciyan T, Magerl M, Martinez-Saguer I, Stobiecki M, Farkas H, Kiani-Alikhan S, Grivcheva-Panovska V, Bernstein JA, Li HH, Longhurst HJ, Audhya PK, Smith MD, Yea CM, Maetzel A, Lee DK, Feener EP, Gower R, Lumry WR, Banerji A, Riedl MA, Maurer M
Hereditary Angioedema With Normal C1 Inhibitor: US Survey of Prevalence and Provider Practice Patterns.
Riedl MA, Danese M, Danese S, Ulloa J, Maetzel A, Audhya PK
Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema.
Duckworth EJ, Murugesan N, Li L, Rushbrooke LJ, Lee DK, De Donatis GM, Maetzel A, Yea CM, Hampton SL, Feener EP
KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results.
Maetzel A, Smith MD, Duckworth EJ, Hampton SL, De Donatis GM, Murugesan N, Rushbrooke LJ, Li L, Francombe D, Feener EP, Yea CM
One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Phase 1B Study.
Sun JK, Maturi RK, Boyer DS, Wells JA, Gonzalez VH, Tansley R, Hernandez H, Maetzel A, Feener EP, Aiello LP
Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.
Aygören-Pürsün E, Magerl M, Maetzel A, Maurer M
Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis.
Sander B, Kwong JC, Bauch CT, Maetzel A, McGeer A, Raboud JM, Krahn M
Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.
Sander B, Bauch CT, Fisman D, Fowler RA, Kwong JC, Maetzel A, McGeer A, Raboud J, Scales DC, Gojovic MZ, Krahn M
Cost-effectiveness estimates reported for tumor necrosis factor blocking agents in rheumatoid arthritis refractory to methotrexate--a brief summary.
Maetzel A
Frequent collaborators
- Jeffrey Kwong and Beate Sander: 48 shared papers
- Jeffrey Kwong and Allison McGeer: 44 shared papers
- Allison McGeer and Beate Sander: 29 shared papers
- Janet Raboud and Allison McGeer: 21 shared papers
- Allison McGeer and David Fisman: 21 shared papers
- David Fisman and Beate Sander: 15 shared papers
- Jeffrey Kwong and David Fisman: 13 shared papers
- Allison McGeer and Damon Scales: 10 shared papers
- Beate Sander and Chris Bauch: 9 shared papers
- Allison McGeer and Chris Bauch: 6 shared papers
- Jeffrey Kwong and Chris Bauch: 5 shared papers
- Janet Raboud and Damon Scales: 4 shared papers
- Janet Raboud and Beate Sander: 4 shared papers
- Janet Raboud and Andreas Maetzel: 2 shared papers
- Jeffrey Kwong and Andreas Maetzel: 2 shared papers
- Allison McGeer and Andreas Maetzel: 2 shared papers
- Beate Sander and Andreas Maetzel: 2 shared papers
- Chris Bauch and Andreas Maetzel: 2 shared papers
- Jeffrey Kwong and Damon Scales: 1 shared paper
- Damon Scales and Andreas Maetzel: 1 shared paper
- David Fisman and Andreas Maetzel: 1 shared paper
- Institute of Health Policy, Management, and Evaluation
- Department of Laboratory Medicine & Pathobiology
- Dalla Lana School of Public Health
- Department of Applied Mathematics
- Biostatistics Division
- Infectious Diseases
- Department of Medicine
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Murray Krahn
Toronto General Research Institute
2 shared papers, latest 2010
Janet Raboud
Biostatistics Division
2 shared papers, latest 2010
Jeffrey Kwong
Infectious Diseases
2 shared papers, latest 2010
Allison McGeer
Department of Laboratory Medicine & Pathobiology
2 shared papers, latest 2010
Chris Bauch
Department of Applied Mathematics
2 shared papers, latest 2010
Christopher Bauch
Department of Applied Mathematics
2 shared papers, latest 2010
Beate Sander
Dalla Lana School of Public Health
2 shared papers, latest 2010
Damon Scales
Department of Medicine
1 shared papers, latest 2010
David Fisman
Epidemiology
1 shared papers, latest 2010
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.